Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

Wanbang Biopharmaceuticals Co. LtdWanbang Biopharmaceuticals Co. Ltd
VS
AbbVieAbbVie
Wanbang Biopharmaceuticals Co. Ltd

Wanbang Biopharmaceuticals Co. Ltd

经济开发区杨山路, 徐州市, 江苏省, 221004, CN

Last Update: 10/12/2025

View Profile
Between 750 and 799
http://www.chinawanbang.com/
751/1000Fair

The Brief Introduction of Wanbang Biopharmaceuticals Wanbang Biopharmaceuticals (brief in “Wanbang Biopharma”) is the core member of Shanghai Fosun Pharmaceutical (Group) Co., Ltd (brief in “Fosun Pharma”, stock code: 600196-SH, 02196-HK). Wanbang Biopharma was establis...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:12
Subsidiaries:28
12-month incidents
0
Known data breaches
0
Attack type number
0
AbbVie

AbbVie

1 Waukegan Road, North Chicago, 60064, US

Last Update: 19/07/2026

View Profile
Between 800 and 849
http://www.abbvie.com
827/1000Good

AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first — for patients, communities, and our world. We aim to address complex health issues and enhance people's lives through our core therapeutic areas: immunology, ...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:61,106
Subsidiaries:19
12-month incidents
1
Known data breaches
1
Attack type number
2

Compliance Ranges Comparison

Based On Specific Ai Models Category
Wanbang Biopharmaceuticals Co. Ltd

Wanbang Biopharmaceuticals Co. Ltd

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
AbbVie

AbbVie

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Wanbang Biopharmaceuticals Co. Ltd in 2026.

Incidents

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

AbbVie has 2.91% fewer incidents than the average of all companies with at least one recorded incident.

Incidents

Incident History - Wanbang Biopharmaceuticals Co. Ltd (X = Date, Y = Severity)

Wanbang Biopharmaceuticals Co. Ltd cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - AbbVie (X = Date, Y = Severity)

AbbVie cyber incidents detection timeline including parent company and subsidiaries.

R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
Wanbang Biopharmaceuticals Co. Ltd

Wanbang Biopharmaceuticals Co. Ltd

Incidents
No explicit notable incidents reported.
AbbVie

AbbVie

Incidents
🔒 Incident : Vulnerability
EGAABB1775658772
🔒 Incident : Breach
ABB0473723

FAQ

Between Wanbang Biopharmaceuticals Co. Ltd company and AbbVie company, which one has the best AI Cybersecurity Score ?
Between Wanbang Biopharmaceuticals Co. Ltd company and AbbVie company, which one has experienced more cyber incidents in the past ?
Between Wanbang Biopharmaceuticals Co. Ltd company and AbbVie company, which one has experienced more cyber incidents this year ?
Between Wanbang Biopharmaceuticals Co. Ltd company and AbbVie company, which one has experienced at least one ransomware attack ?
Between Wanbang Biopharmaceuticals Co. Ltd company and AbbVie company, which one has experienced at least one data breach ?
Between Wanbang Biopharmaceuticals Co. Ltd company and AbbVie company, which one has experienced at least one targeted cyberattack ?
Between Wanbang Biopharmaceuticals Co. Ltd company and AbbVie company, which one has experienced at least one vulnerability ?
Between Wanbang Biopharmaceuticals Co. Ltd company and AbbVie company, which one holds the most compliance certifications ?
Between Wanbang Biopharmaceuticals Co. Ltd company and AbbVie company, which one holds the fewest compliance certifications ?
Between Wanbang Biopharmaceuticals Co. Ltd company and AbbVie company, which one has the most subsidiaries ?
Between Wanbang Biopharmaceuticals Co. Ltd company and AbbVie company, which one has the largest number of employees ?
Between Wanbang Biopharmaceuticals Co. Ltd and AbbVie, which company holds both SOC 2 Type 1 certifications ?
Between Wanbang Biopharmaceuticals Co. Ltd and AbbVie, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - Wanbang Biopharmaceuticals Co. Ltd or AbbVie ?
Which company is PCI DSS compliant - Wanbang Biopharmaceuticals Co. Ltd or AbbVie ?
Between Wanbang Biopharmaceuticals Co. Ltd and AbbVie, which company complies with HIPAA regulations for healthcare data ?
Between Wanbang Biopharmaceuticals Co. Ltd and AbbVie, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-66720
SUMMARY

The GOOSE subscriber component improperly validates the UTC timestamp field in unauthenticated IEC 61850 GOOSE (EtherType 0x88B8) Layer-2 multicast messages. A specially crafted GOOSE frame containing an undersized timestamp field can trigger a heap out-of-bounds read during message processing, causing the process to crash and resulting in a denial-of-service condition.

PUBLISHED
Date2026-07-30
UPDATED
Date2026-07-30
RISK INFORMATION (Score: 6.5)
CVSS3
Base Score: 6.5
Complexity: LOW
CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H
CVSS4
Base Score: 7.1
Complexity: LOW
CVSS:4.0/AV:A/AC:L/AT:N/PR:N/UI:N/VC:N/VI:N/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.6
EXPLOITABILITY
2.8
CVE-2026-66421
SUMMARY

OpenClaw Dashboard contains a stored cross-site scripting vulnerability that allows unauthenticated remote attackers to execute arbitrary JavaScript in the administrator's browser session by injecting HTML markup into agent transcript messages processed through the sessions API. Attackers can craft a message containing inline event handler payloads such as an img tag with an onerror attribute within the 60-character rendering budget, which is stored in the session transcript and interpolated unsanitized into innerHTML on the default landing page, allowing theft of session tokens and unauthorized calls to authenticated administrative endpoints including agent instruction file modification.

PUBLISHED
Date2026-07-30
UPDATED
Date2026-07-30
RISK INFORMATION (Score: 9.3)
CVSS3
Base Score: 9.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:H/I:H/A:N
CVSS4
Base Score: 8.8
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:P/PR:N/UI:P/VC:H/VI:H/VA:N/SC:H/SI:H/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
5.8
EXPLOITABILITY
2.8
CVE-2026-66420
SUMMARY

MeshCentral 1.1.21 contains a cross-site WebSocket hijacking protection bypass vulnerability that allows unauthenticated remote attackers to hijack authenticated administrator sessions by exploiting an unconditional early return in the CheckWebServerOriginName() function within webserver.js when self-signed certificates are in use. Attackers can open cross-origin WebSocket connections to any of the twelve WebSocket endpoints, send crafted action commands to exfiltrate the server sessionKey used to sign session cookies, forge session tokens as arbitrary users, and gain full remote control of all managed devices governed by the MeshCentral instance.

PUBLISHED
Date2026-07-30
UPDATED
Date2026-07-30
RISK INFORMATION (Score: 8.8)
CVSS3
Base Score: 8.8
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H
CVSS4
Base Score: 8.6
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:A/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
5.9
EXPLOITABILITY
2.8
CVE-2026-66369
SUMMARY

The GOOSE parser contains an off-by-one boundary-handling flaw that can be triggered by a single unauthenticated Layer-2 multicast frame on the process bus. When specific GOOSE message fields are processed, the parser advances its internal buffer position incorrectly, resulting in a heap out-of-bounds read. On affected platforms, this condition reliably terminates the subscriber process and causes a denial-of-service.

PUBLISHED
Date2026-07-30
UPDATED
Date2026-07-30
RISK INFORMATION (Score: 6.5)
CVSS3
Base Score: 6.5
Complexity: LOW
CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H
CVSS4
Base Score: 7.1
Complexity: LOW
CVSS:4.0/AV:A/AC:L/AT:N/PR:N/UI:N/VC:N/VI:N/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.6
EXPLOITABILITY
2.8
CVE-2026-66364
SUMMARY

The GOOSE payload parser contains a boundary handling flaw that can be triggered by a single unauthenticated Layer 2 multicast frame on the process bus. When processing specific payload fields, an attacker controlled inner element length may exceed its enclosing length, causing the parser to over read by one byte. This out-of-bounds read reliably terminates the subscriber process, resulting in a denial-of-service condition.

PUBLISHED
Date2026-07-30
UPDATED
Date2026-07-30
RISK INFORMATION (Score: 6.5)
CVSS3
Base Score: 6.5
Complexity: LOW
CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H
CVSS4
Base Score: 7.1
Complexity: LOW
CVSS:4.0/AV:A/AC:L/AT:N/PR:N/UI:N/VC:N/VI:N/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.6
EXPLOITABILITY
2.8